Fig. 7From: Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancerSchematic diagram showing that NORAD increases the expression of RhoA proteins via sponging of its inhibitor miR-125a-3p, thus bridging hypoxia and metastasisBack to article page